|
Q3 FY2026
As of Apr 30, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q1 FY2026
As of Oct 31, 2025
|
Q4 FY2025
As of Jul 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q4 FY2018
As of Jul 31, 2018
|
Q3 FY2018
As of Apr 30, 2018
|
Q2 FY2018
As of Jan 31, 2018
|
Q1 FY2018
As of Oct 31, 2017
|
Q4 FY2017
As of Jul 31, 2017
|
Q3 FY2017
As of Apr 30, 2017
|
Q2 FY2017
As of Jan 31, 2017
|
Q1 FY2017
As of Oct 31, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | |||||||||||||
| Prepaid expenses | |||||||||||||
| Total current assets | |||||||||||||
| Total assets | |||||||||||||
| Accounts payable and accrued expenses | |||||||||||||
| Due to related parties | |||||||||||||
| Notes payable | |||||||||||||
| Total current liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Commitments and Contingencies (See note 5) | |||||||||||||
| Preferred stock, value | |||||||||||||
| Preferred Stock | |||||||||||||
| Series A Preferred Stock | |||||||||||||
| Series B Preferred Stock | |||||||||||||
| Preferred Stocks | |||||||||||||
| Total preferred stock, value | |||||||||||||
| Preferred stock value | |||||||||||||
| Common Shares 750,000,000 authorized shares, par value $0.00001; 40,972,050 and 38,962,050 shares issued and outstanding as of April 30, 2026 and July 31, 2025, respectively | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders' deficit | |||||||||||||
| Total liabilities and stockholders' deficit | |||||||||||||
Loading...